MidwayBiome, is initially developing a proprietary daily dietary supplement to enhance bone health in post-menopausal women. In addition to calcium and vitamin D, Midway’s product contains components that affect interactions between the gastrointestinal tract (or gut) and gut bacterial populations (the Microbiome).
Gut bacteria and their products have been recently found to affect bone health when estrogen levels decrease. Taken orally, our products will help maintain healthy gut barrier integrity and block the effects of pathogenic bacteria that lead to bone loss.
BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its $20 million Greenhouse Fund. BioAdvance invests in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date BioAdvance has committed more than $16 million to 26 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies.
Ben Franklin Technology Partners of Southeastern Pennsylvania is the region's catalyst for Stimulating Entrepreneurial Potential. For over 25 years, Ben Franklin has invested in innovative enterprises and created commercialization pathways and partnerships that generate wealth through science and technology. Ben Franklin is part of the Commonwealth of Pennsylvania's Ben Franklin Technology Partnership. They provide entrepreneurs and established businesses with the Capital, Knowledge and Networks to compete in the global marketplace. They have provided a total of more than $130 million to grow more than 1,600 regional enterprises across all areas of technology.
Ben Franklin Technology Partners of Southeastern Pennsylvania Website
Midway Biome is a privately-held specialty company located in Philadelphia. Midway was founded by gastrointestinal scientists at the University of Chicago in the Departments of Surgery, Digestive Diseases, Infectious Disease and an experienced gastroenterologist and biotech entrepreneur. The initial observations leading to products to maintaining health through gut integrity was extended by a scientist in bone physiology at Michigan State University in collaboration with Midway.
Midway is focused on developing proprietary agents for enhancing health and wellness in people suffering gastrointestinal and systemic disorders. Gut bacteria are increasing thought to influence bone density, obesity, inflammatory bowel disease, irritable bowel syndrome, radiation injury to the gut during cancer therapy, neonatal necrotizing enterocolitis in premature infants, gut bacteria-derived sepsis. And the list keeps growing yearly
We can be reached at: